At ClearSkyMD, we believe the future of healthcare lies in innovation and the ability to harness cutting-edge technology for the...

#ClearSkycompany #StephenSmith #EHDNCongress #Enroll-HDCongress #Huntington'sDisease #TAP-HDstudy #CHDIFoundation #AIinneurology...

Prof. Stephen Smith, the founder of ClearSky, will be attending and speaking at the UK Computational Intelligence Workshop 2024 (UKCI...

ClearSky Medical Diagnostics is a leading innovator of digital technologies tailored for accurate and objective assessment of...

From Protocols to Insights: The Journey of Clinical Research Clinical research plays a crucial role in advancing our understanding of...

Neurodegenerative diseases, such as Alzheimer's and Parkinson's, can have a devastating impact on individuals and their families. These...

Mark your calendars for Monday 4 December 2033 as Professor Stephen Smith takes part in a webinar exploring personalised digital...

ClearSky Medical Diagnostics has been selected as a UK Life Sciences Innovator 2023 by the UK’s Department for International Trade (DIT)....

ClearSky attended MEDICA 2022 in Düsseldorf, Germany as part of the UK Healthcare Pavilion, supported by the Department for International...

The ClearSky Medical Diagnostics team will be attending the International Parkinson and Movement Disorder Society (MDS) Congress in Spain...

ClearSky’s co-founder Professor Stephen Smith discusses disruptive healthcare technologies in neurodegenerative diseases in the latest...

ClearSky Medical Diagnostics recently attended and exhibited at the 35th Global Conference of Alzheimer’s Disease International in June...

ClearSky Medical Diagnostics is supporting a new initiative to better understand the development of children’s brains during their early...

ClearSky Medical Diagnostics and Shanghai Accurature Diagnostics Co Ltd have entered into a strategic cooperation agreement related to...

Essential tremor (ET) is a neurological disorder that causes involuntary and rhythmic shaking. It is estimated that up to six per cent of...

Professor Stephen Smith highlighted the work of ClearSky Medical Diagnostics in diagnosing and monitoring Parkinson’s at a UK–China...

ClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of...

ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology. Data...

We have launched a new study in China to establish introducing bradykinesia as a feature being measured by LID-Monitor. Parkinson’s is...

We were delighted to be invited to showcase our technology and devices at a prestigious innovation exchange event in Leeds in January –...